摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-methoxy-2-butanol | 39010-62-3

中文名称
——
中文别名
——
英文名称
1-methoxy-2-butanol
英文别名
(R)-1-Methoxybutan-2-ol;(2R)-1-methoxybutan-2-ol
1-methoxy-2-butanol化学式
CAS
39010-62-3
化学式
C5H12O2
mdl
——
分子量
104.149
InChiKey
CSZZMFWKAQEMPB-RXMQYKEDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    7
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Homochiral Metal–Organic Cage for Gas Chromatographic Separations
    作者:Sheng-Ming Xie、Nan Fu、Li Li、Bao-Yan Yuan、Jun-Hui Zhang、Yan-Xia Li、Li-Ming Yuan
    DOI:10.1021/acs.analchem.8b01670
    日期:2018.8.7
    Metal–organic cages (MOCs) as a new type of porous material with well-defined cavities were extensively pursued because of their relative ease of synthesis and their potential applications in host–guest chemistry, molecular recognition, separation, catalysis, gas storage, and drug delivery. Here, we first reported that a homochiral MOC [Zn3L2] is explored to fabricate [Zn3L2] coated capillary column
    金属有机笼(MOC)是一种新型的多孔材料,具有明确的空腔,因为它们的合成相对容易,并且在主客体化学,分子识别,分离,催化,气体存储和潜在应用中具有潜在的应用前景。药物输送。在这里,我们第一次报道了纯手性MOC [锌3大号2 ]进行了探索,制作[锌3大号2 ]涂覆毛细管柱为广泛的分析物的高分辨率气相色谱分离,包括Ñ-烷烃,多环芳烃和位置异构体,尤其是外消旋体。在[Zn 3 L 2 ]包被的毛细管色谱柱上以良好的对映选择性和重现性分离了各种外消旋体,例如醇,二醇,环氧化物,醚,卤代烃和酯。制备的[Zn 3 L 2 ]涂层毛细管柱表现出明显的手性识​​别能力,与商业化的β-DEX120色谱柱和我们最近报道的均手性多孔有机笼式CC3-R涂层色谱柱互补。结果表明,在分离科学中,同手性MOC作为一种新型的手性选择剂将具有巨大的吸引力。
  • [EN] PHENOXY BENZAMIDE COMPOUNDS WITH UTILITY IN THE TREATMENT OF TYPE 2 DIABETES AND OBESITY<br/>[FR] COMPOSES DE PHENOXY BENZAMIDE AYANT UNE UTILITE DANS LE TRAITEMENT DU DIABETE DE TYPE 2 ET DE L'OBESITE
    申请人:ASTRAZENECA AB
    公开号:WO2006040528A1
    公开(公告)日:2006-04-20
    Compounds of Formula: (I); wherein: R1 is methoxymethyl; R2 is selected from -C(O)NR4R5, SO2NR4R5, S(O)pR4 and HET-2; HET-1 is a 5- or 6-membered, optionally substituted C-linked heteroaryl ring; HET-2 is a 4-, 5- or 6-membered, C- or N-linked optionally substituted heterocyclyl ring; R3 is selected from halo, fluoromethyl, difluoromethyl, trifluoromethyl, methyl, methoxy and cyano; R4 is selected from for example hydrogen, optionally substituted (1-4C)alkyl and HET-2; R5 is hydrogen or (1-4C)alkyl; or R4 and R5 together with the nitrogen atom to which they are attached may form a heterocyclyl ring system as defined by HET-3; HET-3 is for example an optionally substituted N-linked, 4, 5 or 6 membered, saturated or partially unsaturated heterocyclyl ring; p is (independently at each occurrence) 0, 1 or 2; m is 0 or 1; n is 0, 1 or 2; provided that when m is 0, then n is 1 or 2; or a salt, pro drug or solvate thereof, are described. Their use as GLK activators, pharmaceutical compositions containing them, and processes for their preparation are also described.
    化合物的分子式为:(I);其中:R1为甲氧甲基;R2选择自-C(O)NR4R5、SO2NR4R5、S(O)pR4和HET-2;HET-1为5-或6-成员的、可选择性取代的C-连接杂芳基环;HET-2为4-、5-或6-成员的、C-或N-连接的可选择性取代的杂环烷基环;R3选择自卤素、氟甲基、二氟甲基、三氟甲基、甲基、甲氧基和氰基;R4选择自氢、可选择性取代的(1-4C)烷基和HET-2;R5为氢或(1-4C)烷基;或者R4和R5连同它们连接的氮原子可以形成由HET-3定义的杂环烷基环系统;HET-3例如为可选择性取代的N-连接、4、5或6成员的、饱和或部分不饱和的杂环烷基环;p为(每次独立)0、1或2;m为0或1;n为0、1或2;条件是当m为0时,n为1或2;或其盐、前药或溶剂化合物。描述了它们作为GLK激活剂的用途、含有它们的药物组合物以及它们的制备方法。
  • [EN] BENZAMIDE DERIVATIVES THAT ACT UPON THE GLUCOKINASE ENZYME<br/>[FR] DERIVES DE BENZAMIDE AGISSANT SUR L'ENZYME GLUCOKINASE
    申请人:ASTRAZENECA AB
    公开号:WO2006040529A1
    公开(公告)日:2006-04-20
    Compounds of Formula: (I); wherein: R1 is hydroxymethyl; R2 is selected from -C(O)NR4R5, SO2NR4R5, S(O)pR4 and HET-2; HET-1 is a 5- or 6-membered, optionally substituted C-linked heteroaryl ring; HET-2 is a 4-, 5- or 6-membered, C- or N-linked optionally substituted heterocyclyl ring; R3 is selected from halo, fluoromethyl, difluoromethyl, trifluoromethyl, methyl, methoxy and cyano; R4 is selected from for example hydrogen, optionally substituted (1-4C)alkyl and HET-2; R5 is hydrogen or (1-4C)alkyl; or R4 and R5 together with the nitrogen atom to which they are attached may form a heterocyclyl ring system as defined by HET-3; HET-3 is for example an optionally substituted N-linked, 4, 5 or 6 membered, saturated or partially unsaturated heterocyclyl ring; p is (independently at each occurrence) 0, 1 or 2; m is 0 or 1; n is 0, 1 or 2; provided that when m is 0, then n is 1 or 2; or a salt, pro drug or solvate thereof, are described. Their use as GLK activators, pharmaceutical compositions containing them, and processes for their preparation are also described.
    化合物的化学式:(I);其中:R1为羟甲基;R2选自-C(O)NR4R5,SO2NR4R5,S(O)pR4和HET-2;HET-1为一个5-或6-成员的、可选择地取代的C-连接的杂芳基环;HET-2为一个4-、5-或6-成员的、C-或N-连接的可选择地取代的杂环基环;R3选自卤素、氟甲基、二氟甲基、三氟甲基、甲基、甲氧基和氰基;R4选自例如氢、可选择地取代的(1-4C)烷基和HET-2;R5为氢或(1-4C)烷基;或R4和R5与它们连接的氮原子一起可以形成由HET-3定义的杂环基环系统;HET-3为例如一个可选择地取代的N-连接的、4、5或6成员的、饱和或部分不饱和的杂环基环;p为(每次独立)0、1或2;m为0或1;n为0、1或2;但是当m为0时,n为1或2;或其盐、前药或溶剂化合物。描述了它们作为GLK激活剂的用途,含有它们的药物组合物,以及它们的制备方法。
  • Application of Homochiral Alkylated Organic Cages as Chiral Stationary Phases for Molecular Separations by Capillary Gas Chromatography
    作者:Shengming Xie、Junhui Zhang、Nan Fu、Bangjin Wang、Cong Hu、Liming Yuan
    DOI:10.3390/molecules21111466
    日期:——
    Molecular organic cage compounds have attracted considerable attention due to their potential applications in gas storage, catalysis, chemical sensing, molecular separations, etc. In this study, a homochiral pentyl cage compound was synthesized from a condensation reaction of (S,S)-1,2-pentyl-1,2-diaminoethane and 1,3,5-triformylbenzene. The imine-linked pentyl cage diluted with a polysiloxane (OV-1701)
    分子有机笼化合物由于其在储气、催化、化学传感、分子分离等方面的潜在应用而引起了相当大的关注。 在本研究中,由 (S,S)-1 的缩合反应合成了同手性戊基笼化合物,2-戊基-1,2-二氨基乙烷和1,3,5-三甲酰基苯。用聚硅氧烷 (OV-1701) 稀释的亚胺连接的戊基笼被探索作为一种新型固定相,用于有机化合物的高分辨率气相色谱分离。一些位置异构体在戊基笼包被的毛细管柱上进行基线分离。特别是,包括手性醇、酯、醚和环氧化物在内的各种类型的对映异构体无需在戊基笼涂层毛细管柱上进行衍生化即可得到拆分。使用硝基氯苯和氧化苯乙烯作为分析物研究了用于分离的戊基笼涂层毛细管柱的重现性。结果表明,该色谱柱经反复使用具有良好的稳定性和分离重现性。这项工作表明分子有机笼化合物在不久的将来可能成为一类新型的手性分离介质。
  • Heteroarylcarbamoylbenzene derivative
    申请人:IIno Tomoharu
    公开号:US20060167053A1
    公开(公告)日:2006-07-27
    Compounds represented by formula (I): as well as their pharmaceutically acceptable salts are disclosed. The compounds are useful as glucokinase activating agents for the treatment of diabetes and related conditions. Compositions and methods of treatment are also included.
    公式(I)所代表的化合物及其药学上可接受的盐被披露。这些化合物可用作激活葡萄糖激酶的药剂,用于治疗糖尿病及相关疾病。还包括治疗组合物和方法。
查看更多